Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ronald M Goldenberg

Showing results (41-50 of 48) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 48 results.
Vascular Medicine (London, England)|December 26, 2022
Reduced CT iodine perfusion score is associated with adverse clinical outcomes in acute pulmonary embolismEugene Yuriditsky, Oscar J L Mitchell, William H Moore, et al.
Vascular Medicine (London, England)|November 12, 2019
Low left ventricular outflow tract velocity time integral is associated with poor outcomes in acute pulmonary embolismEugene Yuriditsky, Oscar Jl Mitchell, Rachel A Sibley, et al.
Thrombosis Research|July 12, 2020
Right ventricular stroke distance predicts death and clinical deterioration in patients with pulmonary embolismEugene Yuriditsky, Oscar J L Mitchell, Akhilesh K Sista, et al.
Canadian Journal of Diabetes|December 18, 2018
Glycated Hemoglobin Level Goal Achievement in Adults With Type 2 Diabetes in Canada: Still Room for ImprovementLawrence A Leiter, Alice Y Y Cheng, Jean-Marie Ekoé, et al.
Circulation|November 12, 2019
Effect of Empagliflozin on Erythropoietin Levels, Iron Stores, and Red Blood Cell Morphology in Patients With Type 2 Diabetes Mellitus and Coronary Artery DiseaseC David Mazer, Gregory M T Hare, Philip W Connelly, et al.
Circulation|August 23, 2019
Effect of Empagliflozin on Left Ventricular Mass in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease: The EMPA-HEART CardioLink-6 Randomized Clinical TrialSubodh Verma, C David Mazer, Andrew T Yan, et al.
The Canadian Journal of Cardiology|August 12, 2022
2022 Canadian Cardiovascular Society Guideline for Use of GLP-1 Receptor Agonists and SGLT2 Inhibitors for Cardiorenal Risk Reduction in AdultsG B John Mancini, Eileen O'Meara, Shelley Zieroth, et al.
Respiratory Medicine|July 29, 2018
Respiratory care in familial dysautonomia: Systematic review and expert consensus recommendationsMikhail Kazachkov, Jose-Alberto Palma, Lucy Norcliffe-Kaufmann, et al.
Pageof 5

Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Vascular Medicine (London, England)|December 26, 2022
Reduced CT iodine perfusion score is associated with adverse clinical outcomes in acute pulmonary embolismEugene Yuriditsky, Oscar J L Mitchell, William H Moore, et al.
Vascular Medicine (London, England)|November 12, 2019
Low left ventricular outflow tract velocity time integral is associated with poor outcomes in acute pulmonary embolismEugene Yuriditsky, Oscar Jl Mitchell, Rachel A Sibley, et al.
Thrombosis Research|July 12, 2020
Right ventricular stroke distance predicts death and clinical deterioration in patients with pulmonary embolismEugene Yuriditsky, Oscar J L Mitchell, Akhilesh K Sista, et al.
Canadian Journal of Diabetes|December 18, 2018
Glycated Hemoglobin Level Goal Achievement in Adults With Type 2 Diabetes in Canada: Still Room for ImprovementLawrence A Leiter, Alice Y Y Cheng, Jean-Marie Ekoé, et al.
Circulation|November 12, 2019
Effect of Empagliflozin on Erythropoietin Levels, Iron Stores, and Red Blood Cell Morphology in Patients With Type 2 Diabetes Mellitus and Coronary Artery DiseaseC David Mazer, Gregory M T Hare, Philip W Connelly, et al.
Circulation|August 23, 2019
Effect of Empagliflozin on Left Ventricular Mass in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease: The EMPA-HEART CardioLink-6 Randomized Clinical TrialSubodh Verma, C David Mazer, Andrew T Yan, et al.
The Canadian Journal of Cardiology|August 12, 2022
2022 Canadian Cardiovascular Society Guideline for Use of GLP-1 Receptor Agonists and SGLT2 Inhibitors for Cardiorenal Risk Reduction in AdultsG B John Mancini, Eileen O'Meara, Shelley Zieroth, et al.
Respiratory Medicine|July 29, 2018
Respiratory care in familial dysautonomia: Systematic review and expert consensus recommendationsMikhail Kazachkov, Jose-Alberto Palma, Lucy Norcliffe-Kaufmann, et al.
Pageof 5